Xu L - Search Results

1

The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients.

Pan K, Li YQ, Wang W, Xu L, Zhang YJ, Zheng HX, Zhao JJ, Qiu HJ, Weng DS, Li JJ, Wang QJ, Huang LX, He J, Chen SP, Ke ML, Wu PH, Chen MS, Li SP, Xia JC, Zeng YX. Pan K, et al. Among authors: xu l. Ann Surg Oncol. 2013 Dec;20(13):4305-11. doi: 10.1245/s10434-013-3144-x. Epub 2013 Jul 27. Ann Surg Oncol. 2013. PMID: 23892527

2

[Clinicopathologic features and treatment outcomes of primary hepatic lymphoma: a report of four cases].

Zhang YJ, Chen MS, Liang HH, Xu L, Zhang YQ. Zhang YJ, et al. Among authors: xu l. Ai Zheng. 2005 Mar;24(3):365-7. Ai Zheng. 2005. PMID: 15757544 Chinese.

3

[Multivariate prognostic analysis in gastric carcinoma patients after radical operation].

Zhan YQ, Sun XW, Li W, Chen YB, Xu L, Guan YX, Li YF, Xu DZ. Zhan YQ, et al. Among authors: xu l, xu dz. Ai Zheng. 2005 May;24(5):596-9. Ai Zheng. 2005. PMID: 15890105 Chinese.

4

[Prophylaxis and clinical treatment for surgical margin recurrence of small primary hepatocellular carcinoma].

Fang WQ, Li SP, Zhang CQ, Xu L, Shi M, Chen MS, Li JQ. Fang WQ, et al. Among authors: xu l. Ai Zheng. 2005 Jul;24(7):834-6. Ai Zheng. 2005. PMID: 16004810 Chinese.

5

[Long-term results of surgical treatment of stomach cancer: clinical experience of forty years from Sun Yat-sen University Cancer Center].

Zhan YQ, Li W, Sun XW, Chen YB, Xu L, Chen G, Guan YX, Li YF, Xu DZ, Sun XF, Zhang HZ, Lin ZW. Zhan YQ, et al. Among authors: xu l, xu dz. Zhonghua Wai Ke Za Zhi. 2005 Sep 1;43(17):1109-13. Zhonghua Wai Ke Za Zhi. 2005. PMID: 16194306 Chinese.

6

[Inhibitory effects of iressa on hepatocellular carcinoma Hep-3B and HepG2 cell xenografts in nude mice].

Xu L, Zhang YJ, Lin XJ, Li JQ. Xu L, et al. Ai Zheng. 2006 Apr;25(4):447-50. Ai Zheng. 2006. PMID: 16613678 Chinese.

7

[Influence of surgical resection margin in hepatectomy on survival of patients with hepatocellular carcinoma].

Xu L, Shi M, Zhang YQ, Li JQ. Xu L, et al. Zhonghua Zhong Liu Za Zhi. 2006 Jan;28(1):47-9. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 16737621 Clinical Trial. Chinese.

8

[Clinical significance of the proportion of CD4+CD25+ regulatory T cells in peripheral blood of hepatocellular carcinoma patients: a report of 117 cases].

Peng QQ, Li SP, Xu L, Li JQ. Peng QQ, et al. Among authors: xu l. Ai Zheng. 2007 Jul;26(7):748-51. Ai Zheng. 2007. PMID: 17626752 Free article. Chinese.

9

[Experience of radiofrequency ablation on liver malignancies: a report of 803 cases].

Chen MS, Zhang YJ, Li JQ, Liang HH, Zhang YQ, Lin XJ, Zheng Y, Xu L, Wan YL. Chen MS, et al. Among authors: xu l. Zhonghua Wai Ke Za Zhi. 2007 Nov 1;45(21):1469-71. Zhonghua Wai Ke Za Zhi. 2007. PMID: 18275711 Chinese.

10

Clinicopathologic features and long-term outcomes of Chinese patients with hepatocellular carcinoma in non-cirrhotic liver.

Xu L, Huang L, Li BK, Zhang YQ, Li JQ, Yuan YF. Xu L, et al. Dig Surg. 2008;25(5):376-82. doi: 10.1159/000170881. Epub 2008 Nov 13. Dig Surg. 2008. PMID: 19005256

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41,275 results

Search Page

Filters